SCHEMBL13680679

SCHEMBL13680679

Cc1cccc(-c2cnc(C)nc2)n1

nearest known ligand 0.60

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.60
CCR8 P51685 1/20 0.60
CYP2A6 P11509 1/20 0.56
METAP2 P50579 1/20 0.47
TGFBR1 P36897 11/20 0.44
MAPK14 Q16539 1/20 0.41
GRM5 P41594 1/20 0.40
NOS3 P29474 1/20 0.40
NOS2 P35228 1/20 0.40
BRS3 P32247 1/20 0.38
MEN1 O00255 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13680673 0.84 CCR1 (0.56) CCR1CCR8CYP2A6METAP2TGFBR1
SCHEMBL13680677 0.82 CCR1 (0.54) CCR1CCR8CYP2A6METAP2TGFBR1
SCHEMBL3421947 0.82 CYP2A6 (0.65) CCR1CCR8CYP2A6METAP2TGFBR1
SCHEMBL30146674 0.82 CYP2A6 (0.65) CCR1CCR8CYP2A6METAP2TGFBR1
SCHEMBL13680674 0.81 CCR1 (0.52) CCR1CCR8CYP2A6METAP2TGFBR1
SCHEMBL13680675 0.81 CCR1 (0.52) CCR1CCR8CYP2A6METAP2TGFBR1
SCHEMBL13680680 0.81 CYP2A6 (0.54) CCR1CCR8CYP2A6METAP2TGFBR1
SCHEMBL13680586 0.81 CCR1 (0.52) CCR1CCR8CYP2A6METAP2TGFBR1
SCHEMBL23243795 0.80 CYP2A6 (0.37) CCR1CCR8CYP2A6METAP2GRM5
SCHEMBL13662719 0.80 ASIC3 (0.57) CCR1CCR8CYP2A6NOS3NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023072301-A1 PYRAZOLO[3,4-D]PYRIMIDIN-3-ONE COMPOUND AND MEDICAL USE THEREOF 正大天晴药业集团股份有限公司 2023-05-04 WO disclosed
US-7582658-B2 Bicyclic compound ASAHI KASEI PHARMA CORPORATION (JP) 2009-09-01 US disclosed
US-7582658-B2 Bicyclic compound ASAHI KASEI PHARMA CORPORATION (JP) 2009-09-01 US disclosed